{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T13:28:59Z","timestamp":1680614939261},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.schres.2011.02.019","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T00:39:24Z","timestamp":1301013564000},"page":"83-90","source":"Crossref","is-referenced-by-count":6,"title":["Long term antipsychotic treatment does not alter metabolite concentrations in rat striatum: An in vivo magnetic resonance spectroscopy study"],"prefix":"10.1016","volume":"128","author":[{"given":"Diana M.","family":"Lindquist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Scott","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim M.","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.schres.2011.02.019_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1742-7835.2007.00128.x","article-title":"Effect of antipsychotics on creatine kinase activity in rat brain","volume":"101","author":"Assis","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2011.02.019_bb0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.schres.2009.06.014","article-title":"In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia","volume":"113","author":"Bartzokis","year":"2009","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2011.02.019_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0006-3223(00)00997-5","article-title":"The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia","volume":"49","author":"Bertolino","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2011.02.019_bb0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2010.10.004","article-title":"Proton magnetic resonance spectroscopy and illness stage in schizophrenia \u2014 a systematic review and meta-analysis","volume":"69","author":"Brugger","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2011.02.019_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0925-4927(01)00102-0","article-title":"Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia","volume":"107","author":"Bustillo","year":"2001","journal-title":"Psychiatry Res."},{"issue":"2\u20133","key":"10.1016\/j.schres.2011.02.019_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0920-9964(02)00210-4","article-title":"Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure","volume":"58","author":"Bustillo","year":"2002","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2011.02.019_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0920-9964(02)00528-5","article-title":"Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels","volume":"66","author":"Bustillo","year":"2004","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2011.02.019_bb0040","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.npp.1300874","article-title":"Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels","volume":"31","author":"Bustillo","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.schres.2011.02.019_bb0045","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/sj.npp.1301631","article-title":"Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia","volume":"33","author":"Bustillo","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2011.02.019_bb0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mp.2009.121","article-title":"(1)H-MRS at 4Tesla in minimally treated early schizophrenia","volume":"15","author":"Bustillo","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2011.02.019_bb0055","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.biopsych.2007.05.025","article-title":"Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction","volume":"62","author":"Chang","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2011.02.019_bb0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00004424-199606000-00006","article-title":"Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy","volume":"31","author":"Choe","year":"1996","journal-title":"Invest. Radiol."},{"issue":"4","key":"10.1016\/j.schres.2011.02.019_bb0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.mcn.2006.05.007","article-title":"Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons","volume":"32","author":"Critchlow","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2011.02.019_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00406-003-0398-5","article-title":"Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia","volume":"253","author":"Ende","year":"2003","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2011.02.019_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pscychresns.2009.04.007","article-title":"The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response","volume":"174","author":"Ertugrul","year":"2009","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.schres.2011.02.019_bb0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0006-3223(03)00185-9","article-title":"Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia","volume":"54","author":"Fannon","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2011.02.019_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.schres.2004.11.001","article-title":"Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol","volume":"75","author":"Harte","year":"2005","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2011.02.019_bb0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0925-4927(98)00034-1","article-title":"Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect","volume":"83","author":"Heimberg","year":"1998","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.schres.2011.02.019_bb0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2011.02.019_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/070674370004500302","article-title":"Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench","volume":"45","author":"Kapur","year":"2000","journal-title":"Can. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2011.02.019_bb0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.schres.2011.02.019_bb0105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1046\/j.1471-4159.2003.01866.x","article-title":"Antipsychotic drugs differentially modulate apolipoprotein D in rat brain","volume":"86","author":"Khan","year":"2003","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.schres.2011.02.019_bb0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/(SICI)1522-2594(200003)43:3<355::AID-MRM6>3.0.CO;2-R","article-title":"Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo","volume":"43","author":"Lindquist","year":"2000","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"10.1016\/j.schres.2011.02.019_bb0115","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1021\/pr800892u","article-title":"Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy","volume":"8","author":"McLoughlin","year":"2009","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.schres.2011.02.019_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/15622970701227811","article-title":"Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study","volume":"9","author":"Olbrich","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2011.02.019_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000079972","article-title":"Neuronal dysfunction of the frontal lobe in schizophrenia","volume":"50","author":"Pae","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"5","key":"10.1016\/j.schres.2011.02.019_bb0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.eurpsy.2007.02.005","article-title":"Antipsychotic efficacy: relationship to optimal D2-receptor occupancy","volume":"22","author":"Pani","year":"2007","journal-title":"Eur. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2011.02.019_bb0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00702-007-0004-5","article-title":"Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays","volume":"115","author":"Perez-Costas","year":"2008","journal-title":"J. Neural Transm."},{"issue":"6","key":"10.1016\/j.schres.2011.02.019_bb0140","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson. Med."},{"issue":"8","key":"10.1016\/j.schres.2011.02.019_bb0145","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.npp.1301305","article-title":"Dopamine and serotonin receptor binding and antipsychotic efficacy","volume":"32","author":"Richtand","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.schres.2011.02.019_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresrev.2003.11.001","article-title":"Magnetic resonance spectroscopy in cognitive research","volume":"44","author":"Ross","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.schres.2011.02.019_bb0155","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.neuroimage.2009.10.031","article-title":"Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study","volume":"49","author":"Shirayama","year":"2010","journal-title":"Neuroimage"},{"issue":"11","key":"10.1016\/j.schres.2011.02.019_bb0160","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.npp.1300850","article-title":"Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis","volume":"30","author":"Steen","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2011.02.019_bb0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.biopsych.2009.05.006","article-title":"Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume","volume":"66","author":"Stone","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2011.02.019_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00210-007-0178-2","article-title":"Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain","volume":"376","author":"Streck","year":"2007","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.schres.2011.02.019_bb0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2005-873156","article-title":"The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS)","volume":"38","author":"Szulc","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.schres.2011.02.019_bb0180","first-page":"17","article-title":"N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study","volume":"13","author":"Szulc","year":"2007","journal-title":"Med. Sci. Monit."},{"issue":"1\u20133","key":"10.1016\/j.schres.2011.02.019_bb0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2008.11.014","article-title":"Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)","volume":"108","author":"Tayoshi","year":"2009","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2011.02.019_bb0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pscychresns.2004.04.002","article-title":"Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla","volume":"131","author":"Theberge","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2011.02.019_bb0195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1192\/bjp.bp.106.033670","article-title":"Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia","volume":"191","author":"Theberge","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2011.02.019_bb0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2006.08.011","article-title":"Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D","volume":"89","author":"Thomas","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.02.019_bb0205","article-title":"Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation","author":"Vernon","year":"2010","journal-title":"Biol. Psychiatry."},{"issue":"1\u20133","key":"10.1016\/j.schres.2011.02.019_bb0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.schres.2009.03.036","article-title":"Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus","volume":"111","author":"Yoo","year":"2009","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2011.02.019_bb0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s002130050834","article-title":"The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors","volume":"141","author":"Zhang","year":"1999","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641100140X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641100140X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T22:51:24Z","timestamp":1543877484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641100140X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S092099641100140X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.02.019","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}